A 'universal' flu vaccine is being tested on humans that could end the need for yearly injections.
Vaccines, which are currently available, work only on certain strains of flu, which means a new vaccine must be formulated each year.
Therefore, scientists at Oxford University are carrying out human trials of a new vaccination that targets a different part of the virus to existing methods.
Flu researchers currently face a constant battle to keep up with the regular mutations in the virus.
The new jab will be given to a small number of volunteers to test the dosage before larger trials take place. It will be several years before it comes on the market.